

Henry Schein drops after Q3 results: an EPS beat and raised 2026 guidance are offset by softness in discretionary dental procedures.
You can purchase shares of Henry Schein (NASDAQ:HSIC) through any online brokerage.
Other companies in Henry Schein’s space includes: McKesson Corp (NYSE:MCK), Cencora Inc (NYSE:COR), Cardinal Health Inc (NYSE:CAH), AdaptHealth Corp (NASDAQ:AHCO) and Akso Health Group (NASDAQ:AHG).
Henry Schein has a consensus price target of $89.26.
The stock price for Henry Schein (NASDAQ: HSIC) is $86.05 last updated November 6, 2026 at 4:42 PM EST.
There are no upcoming dividends for Henry Schein.
Henry Schein does not have any upcoming earnings scheduled.
There is no upcoming split for Henry Schein.
Henry Schein is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments...